Shantell Laketa Heiber

Array ( [id] => 6619173 [patent_doc_number] => 20020086035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'HERPEVIRUS REPLICATION DEFECTIVE MUTANTS' [patent_app_type] => new [patent_app_number] => 09/034464 [patent_app_country] => US [patent_app_date] => 1998-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 20274 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086035.pdf [firstpage_image] =>[orig_patent_app_number] => 09034464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4151304 [patent_doc_number] => 06156317 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Immuno-reactive peptide CTL epitopes of human cytomegalovirus' [patent_app_type] => 1 [patent_app_number] => 9/021298 [patent_app_country] => US [patent_app_date] => 1998-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11015 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156317.pdf [firstpage_image] =>[orig_patent_app_number] => 021298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4071239 [patent_doc_number] => 05965356 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Herpes simplex virus type specific seroassay' [patent_app_type] => 1 [patent_app_number] => 9/015815 [patent_app_country] => US [patent_app_date] => 1998-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 4793 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965356.pdf [firstpage_image] =>[orig_patent_app_number] => 015815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4042630 [patent_doc_number] => 05908625 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-01 [patent_title] => 'Use of the protease domain of human plasminogen activator for the treatment of thromboembolic diseases' [patent_app_type] => 1 [patent_app_number] => 9/009044 [patent_app_country] => US [patent_app_date] => 1998-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 6221 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/908/05908625.pdf [firstpage_image] =>[orig_patent_app_number] => 009044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4137451 [patent_doc_number] => 06015795 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-18 [patent_title] => 'Bovine viral diarrhea virus II vaccine and method of immunization' [patent_app_type] => 1 [patent_app_number] => 9/008722 [patent_app_country] => US [patent_app_date] => 1998-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 18095 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/015/06015795.pdf [firstpage_image] =>[orig_patent_app_number] => 008722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045573 [patent_doc_number] => 05968732 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Isothermal transcription based assay for the detection and genotyping of dengue virus' [patent_app_type] => 1 [patent_app_number] => 9/002177 [patent_app_country] => US [patent_app_date] => 1997-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5298 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968732.pdf [firstpage_image] =>[orig_patent_app_number] => 002177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4085793 [patent_doc_number] => 06133023 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Lactic acid bacterial regulatable expression system' [patent_app_type] => 1 [patent_app_number] => 8/981601 [patent_app_country] => US [patent_app_date] => 1997-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 23118 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133023.pdf [firstpage_image] =>[orig_patent_app_number] => 981601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3935236 [patent_doc_number] => 05989548 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Peptide-based composition against papillomavirus infection' [patent_app_type] => 1 [patent_app_number] => 8/945168 [patent_app_country] => US [patent_app_date] => 1997-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 2 [patent_no_of_words] => 14053 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 961 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989548.pdf [firstpage_image] =>[orig_patent_app_number] => 945168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4128270 [patent_doc_number] => 06033845 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Specific diagnostic for feline infectious peritonitis antibodies' [patent_app_type] => 1 [patent_app_number] => 8/993254 [patent_app_country] => US [patent_app_date] => 1997-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8383 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/033/06033845.pdf [firstpage_image] =>[orig_patent_app_number] => 993254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3991459 [patent_doc_number] => 05919616 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Serological assay for herpes' [patent_app_type] => 1 [patent_app_number] => 8/989291 [patent_app_country] => US [patent_app_date] => 1997-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 3638 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919616.pdf [firstpage_image] =>[orig_patent_app_number] => 989291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3987033 [patent_doc_number] => 05985283 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Adenovirus E1A-Associated protein BS69, inhibitor of E1A-transactivation' [patent_app_type] => 1 [patent_app_number] => 8/973675 [patent_app_country] => US [patent_app_date] => 1997-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 8 [patent_no_of_words] => 15349 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985283.pdf [firstpage_image] =>[orig_patent_app_number] => 973675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924287 [patent_doc_number] => 05952216 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => 'Synthetic HPV 16 virus-like particles' [patent_app_type] => 1 [patent_app_number] => 8/987519 [patent_app_country] => US [patent_app_date] => 1997-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5959 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/952/05952216.pdf [firstpage_image] =>[orig_patent_app_number] => 987519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4177250 [patent_doc_number] => 06019978 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Replication-defective adenovirus human type 5 recombinant as a vaccine carrier' [patent_app_type] => 1 [patent_app_number] => 8/973223 [patent_app_country] => US [patent_app_date] => 1997-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 4 [patent_no_of_words] => 12130 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/019/06019978.pdf [firstpage_image] =>[orig_patent_app_number] => 973223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6692232 [patent_doc_number] => 20030039664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'ISOLATED NUCLEOTIDE SEQUENCES ASSOCIATED WITH MULTIPLE SCLEROSIS OR RHEUMATOID ARTHRITIS AND A PROCESS OF DETECTING' [patent_app_type] => new [patent_app_number] => 08/979847 [patent_app_country] => US [patent_app_date] => 1997-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 35938 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20030039664.pdf [firstpage_image] =>[orig_patent_app_number] => 08979847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3905742 [patent_doc_number] => 06001370 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Attenuated strain of the virus causing the porcine reproductive respiratory syndrome (PRRS), and vaccines' [patent_app_type] => 1 [patent_app_number] => 8/930330 [patent_app_country] => US [patent_app_date] => 1997-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 5432 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001370.pdf [firstpage_image] =>[orig_patent_app_number] => 930330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4192962 [patent_doc_number] => 06013265 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Vaccine composition for herpes simplex virus and methods of using' [patent_app_type] => 1 [patent_app_number] => 8/956254 [patent_app_country] => US [patent_app_date] => 1997-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11446 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013265.pdf [firstpage_image] =>[orig_patent_app_number] => 956254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4192864 [patent_doc_number] => 06013258 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Immunogenic peptides from the HPV E7 protein' [patent_app_type] => 1 [patent_app_number] => 8/948378 [patent_app_country] => US [patent_app_date] => 1997-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6176 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013258.pdf [firstpage_image] =>[orig_patent_app_number] => 948378 [rel_patent_id] =>[rel_patent_doc_number] =>)